NDC 51672-4083-01 - Hydrocortisone Butyrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-4083
- Requested NDC
- 51672-4083-01
- Package NDCs from labels
- 51672-4083-5, 51672-4083-7, 51672-4083-1, 51672-4083-2, 51672-4083-6, 51672-4083-01
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd.
- Effective date
- 2026-07-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydrocortisone Butyrate Ointment, 0.1% Hydrocortisone Butyrate Cream USP, 0.1% Hydrocortisone Butyrate Topical Solution, 0.1% | Sun Pharmaceutical Industries, Inc. | Taro Pharmaceutical Industries Ltd. | 2026-07-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-4083-1 | Hydrocortisone Butyrate | 15 g in 1 TUBE | OINTMENT | 15 | 5 | |
| 51672-4083-1 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-2 | Hydrocortisone Butyrate | 30 g in 1 TUBE | OINTMENT | 30 | 5 | |
| 51672-4083-5 | Hydrocortisone Butyrate | 5 g in 1 TUBE | OINTMENT | 5 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 45 g in 1 TUBE | OINTMENT | 45 | 5 | |
| 51672-4083-6 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 1 in 1 CARTON | OINTMENT | 1 | 5 | |
| 51672-4083-7 | Hydrocortisone Butyrate | 10 g in 1 TUBE | OINTMENT | 10 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-4083 | HYDROCORTISONE BUTYRATE SOLUTION HYDROCORTISONE BUTYRATE CREAM HYDROCORTISONE BUTYRATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 5 | Current NDC, Legacy NDC, 9 package rows | 20210409_51176835-598d-4da7-8a00-6bd36f52aa82.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-4083-1 | GM - Gram | 51672-4083 | efb8d4d9-57f2-4954-890a-9738be50e6ed | 1 | 2012-07-24 |
| 51672-4083-6 | GM - Gram | 51672-4083 | 146e42f8-c9cd-4fa2-b41a-089bcca3cb99 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isopropyl Alcohol | ISOPROPYL ALCOHOL | Cariba International | 001c1fcf-2808-467c-86d8-c038513fa3b5 | 2026-01-29 | Warnings | ND2M416302 |
| 70% | ISOPROPYL ALCOHOL | Cariba International | 483586f4-aab4-40c2-8925-c4f7fb22c6aa | 2026-01-29 | Warnings, Adverse reactions | ND2M416302 |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-01-29 | Warnings | PDC6A3C0OX |
| careone hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | American Sales Company | 46794d2e-8fe6-490d-9cfa-ba9b6c209ad6 | 2026-01-29 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Sodium Citrate and Citric Acid | SODIUM CITRATE AND CITRIC ACID MONOHYDRATE | Atlantic Biologicals Corp. | 42d837ae-2578-46df-92d2-24774964aaad | 2026-01-28 | Adverse reactions | XF417D3PSL |
| Regener-Eyes Ophthalmic Solution PROFESSIONAL | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 49771efa-6682-51d0-e063-6294a90a18a5 | 2026-01-28 | Warnings | PDC6A3C0OX |
| Regener-Eyes Ophthalmic Solution LITE | GLYCERIN OPHTHALMIC SOLUTION | M & M PRODUCTS, LLC | 497763ee-dc70-bb48-e063-6294a90afb3d | 2026-01-28 | Warnings | PDC6A3C0OX |
| Singular Wipes Unscented | ISOPROPYL ALCOHOL | SINGULAR ENTERPRISES LLC | ac2b352f-6cb2-4683-bb41-13e8ecb186bf | 2026-01-27 | Warnings | ND2M416302 |
| VERADEX-E | PETROLATUM AND LANOLIN | ABBE Laboratories, Inc. | 00100102-c245-4b63-a4ff-794cacda6f17 | 2026-01-24 | Warnings | 4T6H12BN9U |
| Everlit Survival Sting Relief Pad | ISOPROPYL ALCOHOL | EVERLIT GLOBAL INC. | 3a0414ea-f862-aa0f-e063-6294a90aecb7 | 2026-01-23 | Warnings | ND2M416302 |
| EVERLIT SURVIVAL PREP PAD | ISOPROPYL ALCOHOL | EVERLIT GLOBAL INC. | 3a03ed81-5b1d-172e-e063-6394a90ac59c | 2026-01-23 | Warnings | ND2M416302 |
| foster and thrive hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Strategic Sourcing Services LLC | 9da843f2-e88c-432e-b091-a6acf81d856b | 2026-01-22 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Rite Aid Isopropyl Alcohol Wipes | ISOPROPYL ALCOHOL | Rite Aid | bca837b0-5044-4e97-e053-2a95a90a13af | 2026-01-22 | Warnings | ND2M416302 |
| Designer Lip Smoothie SPF 15 Lip Balm | AVOBENZONE, OCTISALATE, HOMOSALATE, PETROLATUM | Australian Gold | 6fd1bd4f-ef94-42b5-a26c-2a02718c113f | 2026-01-22 | Warnings | 4T6H12BN9U |
| Australian Gold SPF 15 Lip Balm | OCTINOXATE, OCTOCRYLENE, OXYBENZONE, OCTISALATE, PETROLEUM JELLY | Australian Gold | 92966c2d-b61a-4f8b-a5c1-8dfb6352c82f | 2026-01-22 | Warnings | 4T6H12BN9U |
| Australian Gold SPF 30 Lip Balm | AVOBENZONE, HOMOSALATE, OCTISALATE, PETROLATUM | Australian Gold | 32725ca7-ec21-4643-bdc6-278fd647b95d | 2026-01-21 | Warnings | 4T6H12BN9U |
| Australian Gold SPF 30 Lip Balm | AVOBENZONE, HOMOSALATE, OCTISALATE, PETROLATUM | Australian Gold | e6877f7a-3aaa-4096-bcb5-eae0aa2532e5 | 2026-01-21 | Warnings | 4T6H12BN9U |
| Lights Isopropyl Alcohol Prep Pads | ISOPROPYL ALCOHOL | Lights Medical Manufacture Co., Ltd. | 4905a27c-6cf8-4b1a-a02c-4c81756e8c0a | 2026-01-21 | Warnings | ND2M416302 |
| LIGHTS Instant Sting Relief Pad | BENZOCAINE | Lights Medical Manufacture Co., Ltd. | 28dd82a7-f360-a022-e063-6394a90a3a76 | 2026-01-21 | Warnings | ND2M416302 |
| DOP Isopropyl Rubbing Alcohol 70% | ISOPROPYL ALCOHOL | Omega & Delta Co., Inc. | c779a35b-1118-4560-8d77-6878edb4c267 | 2026-01-21 | Warnings | ND2M416302 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.